The combination treatment alleviates the tumor immunosuppressive phenotype One of the challenges in cancer treatment is the immune suppression mediated by the tumor and its surrounding microenvironment, leading to poor therapeutic responsiveness
Research on VPA glucuronide conjugation has focused on several genes of the UGT1A and UGT2B families, including the UGT1A3, UGT1A4, UGT1A8, UGT1A9, UGT1A10, and UGT2B15 genes, as well as the best-studied UGT1A6 and UGT2B7 genes
Consult with your health care provider for diagnosis and treatment of all medical conditions
Article: What are the Benefits of Liposomal Glutathione with NAC
3. No Unwanted Ingredients: Liposomal delivery relies on fats and emulsifiers, which can cause digestive upset or add unnecessary calories